Single-cell and bulk transcriptomics uncovers PRKD2-driven tumor stemness and progression in multiple myeloma.

Sci Rep · 2025 · PMC12540753 · PMID 41120632

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

did not reach statistical significanceP = 0.17not close (p > 0.1)

Although overall survival (OS) was shorter in the PRKD2-high group, the difference did not reach statistical significance ( P = 0.17; Fig.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.